Absorption Systems announce partnership with Synerzys.
Partnership to develop new MS analyzers.
Partnership allows expansion in the Japanese market.
Rapid, low-cost meningitis device, “as simple as pregnancy test strips”.
Nuclea Biotechnologies forms alliance with Wilex, Inc. to advance personalized treatment for breast cancer sufferers
Nuclea’s oncologists will have access to Wilex’s biomarker test for monitoring HER-2/neu in breast cancer patients.
Scientists have developed a blood test to track the resistance of tumors in real time.
New microarray developed by Oxford Gene Technology is to facilitate understanding of cancer formation and development
CytoSureTM Cancer +SNP array to enable the development of more targeted anti-cancer therapies.
Partnership provides first single blood test for dementia.
Partnership’s research initiatives announced in the field of glycomics to enhance innovation using analytical methods.
Research collaboration focuses on prostate cancer biomarkers.